Prostate Virtual High-dose-rate Brachytherapy Boost: 5-Year Results from the PROMETHEUS Prospective Multicentre Trial

- Wegener, Eric, Sidhom, Mark, Arumugam, Sankar, Keats, Sarah, Brown, Simon, Glyde, Alan, Martin, Jarad M., Pryor, David, Bucci, Joseph, Yeoh, Kenway, Richardson, Matthew, Greer, Peter, Wilton, Lee, Gallagher, Sarah, Schmidt, Laurel

Genitourinary Quality-of-Life Comparison Between Urethral Sparing Prostate Stereotactic Body Radiation Therapy Monotherapy and Virtual High-Dose-Rate Brachytherapy Boost

- Richardson, Matthew, Sidhom, Mark, Pryor, David, Siva, Shankar, Martin, Jarad, Keall, Paul, Leigh, Lucy, Ball, Helen, Bucci, Joseph, Gallagher, Sarah, Greer, Peter, Hayden, Amy J., Kneebone, Andrew

A prospective, multi-centre trial of multi-parametric MRI as a biomarker in anal carcinoma

- Jones, Michael, Hruby, George, Holder, Carl, Oldmeadow, Christopher, Martin, Jarad, Coolens, Catherine, Driscoll, Brandon, Stanwell, Peter, Kumar, Mahesh, Capp, Anne, Sridharan, Swetha, Arm, Jameen, Gallagher, Sarah

FDG-PET parameters predict for recurrence in anal cancer - results from a prospective, multicentre clinical trial

- Jones, Michael Peter, Hruby, George, Martin, Jarad, Metser, Ur, Sridharan, Swetha, Capp, Anne, Kumar, Malesh, Gallagher, Sarah, Rutherford, Natalie, Holder, Carl, Oldmeadow, Christopher

Phase 2 multicenter study of gantry-based stereotactic radiotherapy boost for intermediate and high risk prostate cancer (PROMETHEUS)

- Pryor, David, Sidhom, Mark, Martin, Jarad, Arumugam, Sankar, Bucci, Joseph, Gallagher, Sarah, Smart, Joanne, Grand, Melissa, Greer, Peter, Keats, Sarah, Wilton, Lee

Infections after fiducial marker implantation for prostate radiotherapy: are we underestimating the risks?

- Loh, Jasmin, Baker, Katie, Sridharan, Swetha, Greer, Peter, Wratten, Chris, Capp, Anne, Gallagher, Sarah, Martin, Jarad